ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

Also Cancer incidence, mortality level off after declines in 1990s.

September 12, 2003

Cancer Letter Skips Next Two Weeks

September 2, 1988

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

NCI Begins TAILORx Study.

May 26, 2006

NIH Begins Undiagnosed Diseases Program.

May 30, 2008

Danish Researchers Post Long-Awaited Aranesp Results–Ever So Discreetly.

February 16, 2007